Marginal Zone Lymphomas With Plasmacytic Differentiation and Related Disorders

被引:61
作者
Molina, Thierry J. [2 ]
Lin, Pei [3 ]
Swerdlow, Steven H. [4 ]
Cook, James R. [1 ]
机构
[1] Cleveland Clin, Dept Clin Pathol, Cleveland, OH 44195 USA
[2] Univ Paris 05, AP HP, Hotel Dieu, Serv Anat & Cytol Pathol, Paris, France
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA
关键词
Society for Hematopathology/European Association for Haematopathology Workshop; Marginal zone lymphomas; Plasmacytic differentiation; B-CELL LYMPHOMA; HEAVY CHAIN DISEASE; MALT LYMPHOMA; TRANSLOCATIONS; LYMPHOCYTES; DIAGNOSIS;
D O I
10.1309/AJCP63OGXHXCSKSC
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Marginal zone lymphomas of all types (nodal, splenic, and extranodal mucosa-associated lymphoid tissue [MALT]) may show plasmacytic differentiation. Distinguishing marginal zone lymphomas from other small B-cell lymphomas with plasmacytic differentiation, especially lymphoplasmacytic lymphoma, or from plasma cell neoplasms may be challenging. Marginal zone lymphomas with plasmacytic differentiation were discussed in 2 sessions of the 2009 Society for Hematopathology/European Association for Haematopathology Workshop. Session 4 focused on nodal marginal zone lymphomas, including cases exhibiting classic features and cases displaying atypical phenotypes. The difficulties of classification of cases with increased numbers of large cells were also discussed. Session 5 examined nonnodal marginal zone lymphomas and related entities, including splenic marginal zone lymphoma, MALT lymphoma, gamma heavy chain disease, and cryoglobulin-associated lymphoproliferative disorders. These cases illustrate the importance of clinical data and, in some cases, phenotypic and cytogenetic findings in appropriately applying the 2008 World Health Organization criteria.
引用
收藏
页码:211 / 225
页数:15
相关论文
共 51 条
[1]  
[Anonymous], 2008, WHO CLASSIFICATION T
[2]  
[Anonymous], WHO CLASSIFICATION T
[3]  
[Anonymous], WHO CLASSIFICATION T
[4]   Nodal marginal zone lymphoma: current knowledge and future directions of an heterogeneous disease [J].
Arcaini, Luca ;
Lucioni, Marco ;
Boveri, Emanuela ;
Paulli, Marco .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (03) :165-174
[5]  
Burke JS, 1999, AM J CLIN PATHOL, V111, pS133
[6]   Nodal marginal zone lymphoma:: A heterogeneous tumor -: A comprehensive analysis of a series of 27 cases [J].
Camacho, FI ;
Algara, P ;
Mollejo, M ;
García, JF ;
Montalbán, C ;
Martínez, N ;
Sánchez-Beato, M ;
Piris, MA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) :762-771
[7]   Primary nodal marginal zone lymphomas of splenic and MALT type [J].
Campo, E ;
Miquel, R ;
Krenacs, L ;
Sorbara, L ;
Raffeld, M ;
Jaffe, ES .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (01) :59-68
[8]   Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece [J].
Campo, E ;
Chott, A ;
Kinney, MC ;
Leoncini, L ;
Meijer, CJLM ;
Papadimitriou, CS ;
Piris, MA ;
Stein, H ;
Swerdlow, SH .
HISTOPATHOLOGY, 2006, 48 (05) :481-504
[9]  
Chan WC, 1997, BLOOD, V89, P3909
[10]   Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia [J].
Charles, Edgar D. ;
Green, Rashidah M. ;
Marukian, Svetlana ;
Talal, Andrew H. ;
Lake-Bakaar, Gerond V. ;
Jacobson, Ira M. ;
Rice, Charles M. ;
Dustin, Lynn B. .
BLOOD, 2008, 111 (03) :1344-1356